News Daily News Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval Michael O'Riordan March 03, 2021
News Daily News Post-TIA Stroke Risk Has Come Down Over Time, but Vigilance Still Needed Todd Neale January 28, 2021
News Daily News Hospitalization for HF After Acute MI More Common in Women Than Men L.A. McKeown January 15, 2021
News Daily News FDA Passes on Inclisiran, Citing Manufacturing Site Problems Shelley Wood December 23, 2020
News Daily News AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More Shelley Wood December 17, 2020
News Daily News Inclisiran Approved in Europe for Lowering LDL Cholesterol Michael O'Riordan December 11, 2020
News Daily News Increased ASCVD Risk With Inflammatory Bowel Disease Merits Team-Based Care Caitlin E. Cox December 08, 2020
News Daily News Bariatric Surgery Tied to Better Long-term Outcomes After MI Todd Neale October 27, 2020
News Conference News EAS 2020 Just One-Third of European Patients Get to LDL Cholesterol Goals Michael O'Riordan October 13, 2020
News Daily News Different Markers of Dyslipidemia Could Help Fine-tune CVD Prevention Yael L. Maxwell April 28, 2020
News Features ‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19 Michael O'Riordan April 07, 2020
News Opinion Editor's Corner A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out Shelley Wood March 16, 2020
News Daily News ‘Stronger’ Evidence That High Lp(a) Concentrations Cause CVD Yael L. Maxwell December 12, 2019
News Daily News Counting CPCs May Beat Stress Tests for Stratifying CAD Risk Yael L. Maxwell December 11, 2019
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Conference News AHA 2019 Early Data Favorable for New RNAi Therapies to Reduce Triglycerides Caitlin E. Cox November 19, 2019
News Conference News ESC 2019 Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories Yael L. Maxwell September 06, 2019
News Conference News ESC 2019 New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL Michael O'Riordan September 05, 2019
News Conference News ESC 2019 Lifelong Exposure to Lower LDL and BP Linked With Big Reduction in CVD Events Michael O'Riordan September 02, 2019
News Conference News ESC 2019 Evolocumab in Acute ACS Safely Reduces LDL Cholesterol: EVOPACS Yael L. Maxwell August 31, 2019